Amprion’s mission: To revolutionize brain disease diagnosis. Through molecular testing, we aim to accelerate precision medicine for neurodegenerative disorders.
As a pioneer in detecting misfolded proteins, we believe precision medicine is the new frontier. We strive to positively impact brain disease diagnosis and treatment as the world population ages rapidly. Please take a look at our evolving scientific journey below.
Amprion has some important news we need to share with you!
To improve patient access to the SYNTap® biomarker test (CSF), Amprion is reducing the self-pay price for tests with service dates on or after July 1, 2023.
Old self-pay price: $1500.00. New self-pay price: $995.00
Effective July 1, 2023, there is a New ABN (Advanced Beneficiary Notification) form for use when ordering the SYNTap® biomarker test (CSF) for patients on Medicare. Order Process